Lawsuits and legislation around the country would restrict access to or ban mifepristone, often based on the same talking points promoted by anti-abortion groups that experts say are not rooted in scientific evidence. A hearing in the Louisiana case that could decide future telehealth access to abortion medication took place at the John M. Shaw U.S. Courthouse in Lafayette, Louisiana, in late…